Tag Archives: spike protein

Dr Robert Hess: Managing the Covid-19 aftermath

Dr Robert HEss

Dr Robert Hess – 03/07/2022

Dr Robert Hess: Managing the Covid-19 aftermath: Detox of the spike-protein.

Two full years after the pandemic began, it is now time to consider our next moves. In order to maintain a clear overview, I placed great emphasis on accurate documentation and ongoing information exchange right from the start. This meticulous approach, together with insights from science and research findings, enabled us to make precisely tailored recommendations for our clients. In the last few weeks and months, we have been gathering up loose ends and shifting our focus to appropriate preventive measures as well as preparations for the aftermath of the Covid-19 pandemic. In addition to shortening test intervals and adapting diagnostic methods, we will now also review the composition of our supplements to ensure that they are likewise optimally adjusted to the individual pandemic-related circumstances of our clients.


The focus of our prophylactic supplement program and of the measures we are taking for the COVID-19 aftermath is primarily on the spike protein. The spike protein, which is not only a component of the SARS-CoV-2 virus but also produced in our bodies as a result of vaccination, can circulate in our bodies and damage cells, tissues and organs. It is our view that “detoxing” the body of spike proteins as soon as possible after infection or vaccination can protect against damage from residual or circulating spike proteins. Various international committees have been drawing up guidelines and collating information on how to remove viral and vaccine-induced spike proteins from the body. The lists of herbal medicines and dietary supplements together with the information on them were compiled in collaboration with international physicians, scientists and health practitioners.

COVID-19 infection, COVID-19 vaccines and spike protein damage are all relatively new phenomena, so the guidelines have been based on established and recent medical research as well as the clinical experience of international physicians. The respective guidelines will be updated on an ongoing basis as new knowledge and findings emerge. We will review the guidelines, herbal medicines and dietary supplements, as well as other measures and, as appropriate, incorporate them into our program and adapt them individually for our clients.

What exactly is the spike protein?
The SARS-CoV-2 virus first identified in Wuhan has spike protein on its surface. The spike protein is also found in all SARS-CoV-2 variants. In a natural infection, the spike protein is the component of the virus that allows it to enter the cells of your body. One region of the protein, called S2, binds the viral envelope to the cell membrane. The S2 region also has the effect of making the SARS-CoV-2 spike protein easily recognizable to the immune system, which then produces antibodies that attack and bind to the virus.
Spike proteins are also produced by the human body following vaccination against COVID-19 and function in a similar way, in that they can fuse with cell membranes. It is not yet entirely clear to what extent spike proteins formed by vaccination interact with our immune system, as they are produced in our own cells, but this does not necessarily mean that an immune response cannot also be triggered. Misdirected immune responses (i.e. the inability of our immune system to distinguish between virus-related and vaccine-produced spike protein) could have devastating consequences and damage healthy cells in our body.

Why should I consider a spike protein detox?
Recent research has linked viral spike protein to negative effects and consequences, such as blood clots, brain fog, pneumonia, and heart muscle inflammation. A Japanese-led biodistribution study examining the Pfizer/BioNTech vaccine also demonstrated that the vaccine particles had reached various tissues throughout the body within 48 hours of vaccination and did not remain at the injection site, with high concentrations found in the liver, bone marrow and ovaries. New evidence also shows that the spike protein may interfere with the ability of our cells to repair DNA. All of the above taken in the context of Long Covid prompted us to focus more on this issue. Taking preventive action in this area could be of tremendous benefit on multiple levels.

If you have had side-effects after being vaccinated or if you suffer from Long Covid or Long Covid-like symptoms, the “Spike Detox” is one of the best ways to tackle your symptoms. Even if you have not experienced any of the above phenomena and have ever been vaccinated or infected with COVID-19 (with or without symptoms), this is relevant to you. Spike protein induced by a natural infection or alternatively a COVID-19 vaccine has high potential to damage our cells, so it is important to take steps to detoxify the body as much as possible.

What is the purpose of the Spike Detox?
General measures such as heat therapies, sauna sessions and hot baths, are good ways to detoxify from spike protein. Intermittent fasting, a dietary measure that stimulates the body’s autophagy ability, can also be helpful in this context. This is essentially a recycling process that takes place in human cells, whereby cells break down and recycle components. By means of autophagy, the body eliminates damaged cell proteins and can destroy harmful viruses and bacteria resulting from an infection.

The right diet is, of course, also essential here, the consumption of pro-inflammatory foods should be avoided, and it also makes sense to aim for a low-histamine diet. The daily intake of important multivitamins and minerals is essential – we already cover this with our personalized supplements.

The targeted spike protein detox primarily refers to four different components, which we will discuss in more detail below:

– the spike protein
– ACE2 receptors
– interleukin 6 (IL-6)
– furin

“Protein-binding inhibitors” impede the binding of the spike protein to human cells, while others neutralize the spike protein, rendering it potentially incapable of causing damage to human cells.

Spike protein inhibitors: prunella vulgaris, pine needles, emodin, neem, dandelion leaf extract, ivermectin

Spike protein neutralizers: N-acetylcysteine (NAC), glutathione, fennel tea, star anise tea, pine needle tea, St. John’s wort, comfrey leaves, vitamin C

Ivermectin has been shown to bind to the spike protein, potentially preventing it from binding to the cell membrane. A number of naturally occurring plants – including pine needles, fennel, star anise, St. John’s wort, and comfrey leaves – contain a substance called shikimic acid that may help neutralize the spike protein. Shikimic acid is also believed to counteract the formation of blood clots. Pine needle tea has a strong antioxidant effect and contains high concentrations of vitamin C, which has a key role to play in neutralizing toxins.

What are ACE2 receptors?
ACE2 receptors are found in the cell wall, in the epithelial and endothelial lining of lungs and blood vessels, and in blood platelets (thrombocytes). Spike protein binds to ACE2 receptors, and it is thought that variable concentrations of spike protein can bind and adhere to our ACE2 receptors, blocking their regular function in various tissues. In addition, the “stickiness” of the spike protein at the ACE2 receptor could cause the immune system to attack healthy cells and possibly trigger autoimmune diseases.

Substances that can naturally protect ACE2 receptors: ivermectin, quercetin (with zinc), fisetin

There is evidence that, when ivermectin binds to an ACE2 receptor, this prevents the spike protein from binding to it.

Why attack IL-6?
Some natural substances support the detoxification process after infection by acting on interleukin- 6. It has been scientifically proven that cytokines such as IL-6 are present at much higher levels in individuals who have been infected with COVID-19 than in those who have not. IL-6 has also been used as a parameter for measuring the progression of COVID-19 cases. In 2021, a meta-analysis using worldwide datasets showed a correlation between IL-6 levels and the severity of COVID-19 disease and demonstrated that IL-6 levels were inversely related to the number of T cells in ICU patients.

IL-6 inhibitors (anti-inflammatories): Boswellia serrata (frankincense) and dandelion leaf extract

Other IL-6 inhibitors: black cumin (Nigella sativa), curcumin, fish oil and other fatty acids, cinnamon, fisetin (flavonoid), apigenin, quercetin (flavonoid), resveratrol, luteolin, vitamin D3 (with vitamin K), zinc, magnesium, jasmine tea, spices, bay leaves, black pepper, nutmeg, and sage

Several natural, plant substances are used in antiviral therapy. The plant pigment quercetin has been shown to have broad-spectrum anti-inflammatory and antiviral effects. Zinc acts as a powerful antioxidant that protects the body from oxidative stress, a process associated with DNA damage, excessive inflammation and other harmful effects.

What is furin?
Furin is an enzyme that cleaves proteins and makes them biologically active.
Furin has been shown to cleave the spike protein, allowing the virus to enter human cells. There is a furin cleavage site on the spike protein of COVID-19, which is thought to make the virus more infectious and transmissible. Furin inhibitors could therefore prevent cleavage and thus activation of the spike protein.

Furin inhibitors: rutin, limonene, baicalein, hesperidin

Many of these measures and detox options are already part of our program. All further suggestions and research results will be reviewed in the coming weeks for our clients and, if we consider them to be necessary, safe and prophylactic, they will be individually incorporated into the supplements. It is therefore of enormous benefit that we are up to date regarding the infection, recovery and vaccination situation of each client. If you have any further questions or if we do not have all the information about your individual situation, please do not hesitate to contact your consultant.

Dr Robert Hess: In rare cases

Dr Robert HEss

Dr Robert Hess – 02/28/2022

Dr Robert Hess: In rare cases, coronavirus vaccines may cause Long Covid-like symptoms.

As mentioned on Long Covid and potential risk factors, the symptomatology of this condition can be very similar to the side-effects and possible long-term consequences of vaccination. While preliminary data suggests that getting yourself vaccinated significantly reduces your risk of succumbing to Long Covid, there have also been cases where vaccination has caused Long Covid-like symptoms – and for a lengthy period of time.


We always take a balanced view, so that our clients are optimally informed and can weigh up the available information accordingly. There are no official figures, nor have there been any large-scale studies on this phenomenon as yet, but the symptoms, the link to vaccination and the accounts given by those affected are currently being investigated by the National Institute of Health (NIH) and other researchers around the world.

Previous studies have been too limited in scope and have not allowed 100% conclusions to be drawn about whether any of the vaccines have caused some rare form of long-term health problem and, if so, by what mechanism.

Long Covid-like symptoms such as fatigue, brain fog, insomnia, headaches, blood pressure fluctuations and various others are currently being investigated for a possible link to the administration of a COVID-19 vaccine. A number of scientists and research institutes are looking into this matter, among them neuroimmunologist Avindra Nath, clinical director of the Neurological Diseases Institute of the U.S. National Institutes of Health (NIH). In the specialist journal Science, he posited “temporal associations” between vaccination and Long Covid symptoms, but he would not be drawn on whether there was an “etiological association” (i.e. a causative link). Studies conducted by Nath on around 30 case reports have so far remained unpublished, but publication is expected soon.

Much remains unclear about Long Covid, especially the cause of its non-specific symptoms. It is broadly assumed that there is an underlying persistent immune dysregulation, in other words a defective immune response. Some candidates for further research are beta-interferons, immunoglobulins, mini blood clots and autoantibodies.

The Science article also explores the role of autoantibodies – their importance is recognized not only in acute CoV-2 infection, but also in Long Covid. According to recent studies, autoantibodies can be detected up to six months after infection, and as Harald Prüss, a neurologist at the German Center for Neurodegenerative Diseases (DZNE) and at the Charité Hospital in Berlin, writes in an as yet unpublished paper, they are capable of damaging brain tissue. Experiments on animals have suggested that antibodies targeting the SARS-CoV-2 spike protein – the same protein that many vaccines use to trigger a protective immune response – could cause collateral damage. While searching for antibody therapies for COVID-19 in 2020, Harald Prüss and his colleagues discovered that, of the 18 antibodies they identified with strong efficacy against SARS-CoV-2, four also attacked healthy tissue in mice – an indication that they could trigger autoimmune problems.

Initial clinical data point in a similar direction. Last year, researchers testing people infected with SARS-CoV-2 found unusually high levels of autoantibodies, which can attack the body’s own cells and tissues. In the May 2021 issue of Nature magazine, immunologists Aaron Ring and Akiko Iwasaki and their colleagues at the Yale School of Medicine reported finding autoantibodies in acute COVID-19 patients that were targeting the immune system and brain. They are now investigating how long the autoantibodies persist and the extent to which they can damage tissues. In January of this year, Cedars-Sinai Medical Center cardiologist Susan Cheng and protein chemist Justyna Fert-Bober reported in the Journal of Translational Medicine that autoantibodies can still be present up to six months after infection, although the researchers did not link their persistence to long-term symptoms.

To find out whether such autoantibodies harm humans, scientists at the German Center for Neurodegenerative Diseases (DZNE) are testing cerebrospinal fluid from Long Covid patients for antibodies that react to brain tissue obtained from mice: if there is indeed a reaction, these antibodies could also attack human neural tissue. Prüss and his team have published a paper in which they describe finding autoantibodies in at least one third of these patients, which are capable of attacking mouse neurons and other brain cells.

In August 2021, a group at Northwestern University reported in an advance publication that, in patients with neurological complications after COVID-19, a subset of T cells is persistently activated, similar to how it would be in persistent SARS-CoV-2 infection, suggesting an aberrant immune response or a lingering virus.

Scientists investigating possible side-effects are faced with a dilemma: their work risks stoking opposition to vaccines that currently seem to be “safe and effective” (this statement cannot be made with 100% certainty. After all, we have only been vaccinating for about 2 years and we are therefore rather cautious with these statements). “You have to be very careful about associating COVID-19 vaccines with complications,” Nath cautions. “People can draw the wrong conclusions. The implications are enormous.” Complex and persistent symptoms like those experienced by most sufferers are even more difficult to study, because patients often don’t have a clear diagnosis.

At the same time, understanding these problems could help those who currently suffer from them and, if a link is found, help in the development of the next generation of vaccines, perhaps identifying the ones that pose a high risk of serious adverse events. “We shouldn’t be averse to adverse events,” is how William Murphy, an immunologist at the University of California, sums it up. In November 2021, he suggested in The New England Journal of Medicine that an autoimmune mechanism triggered by the SARS-CoV-2 spike protein could explain not only the Long Covid symptoms but also some rare vaccine side-effects, and he called for more basic research to investigate possible links. He also maintains that it is more important to reassure the public that everything is being done in research to understand vaccines than to just say everything is safe, an assertion that we also endorse.

In the meantime, many affected people feel they have been let down by the health care system. The issue is sadly neglected, poorly defined and also politically sensitive, so family doctors and hospitals have not yet taken any initiatives. Many would like to see a network of specialist outpatient clinics for people with Long Covid and Long Covid-like symptoms, sharing their knowledge and experience.

Long Covid symptomatology after vaccination seems to be rare so far. Nevertheless, this is a topic that needs to remain in focus and be subjected to greater in-depth investigation. Overall, there are still too many unknowns and therefore there are currently no approved and effective therapies on the market. Nevertheless, we are able to take preventive action. We have already adapted our prophylactic measures in this regard, and we will also revise our supplements. We are one step ahead in this regard and we have put together effective options exclusively for our clients. Next we will report on how to best protect yourself from long-term effects and just how useful a “detox” of the spike protein can be.

If you have any questions about Long Covid or specific symptoms, please do not hesitate to contact your Consultant. We will continue to monitor this issue closely and to update our knowledge.

Dr Robert Hess: Updates and Revises

Dr Robert HEss

Dr Robert Hess – 02/04/2022

Dr Robert Hess: Updates and Revises Section 4 of its Prophylactic concept.

In the current circumstances, it is more important than ever to maintain a clear overview. The number of vaccinations and infections, the virus variants in circulation and the available vaccines, the course taken by an infection, possible side-effects and the administration of various drugs against severe COVID-19 – these are all factors that make our efforts to provide comprehensive protection more complex, requiring close attention and detailed documentation. Protection of the organism as a whole remains our priority, which is why we are now broadening the scope of our prophylactic concept and scheduled check-ups.

In the last two years, our immune system has been through a lot – it has had to adapt and evolve, to adjust and play a supportive role in meeting the new challenges of either infection with COVID-19 or injection with an mRNA vaccine. To complicate matters, a pandemic is a fast-moving and generally unpredictable state of affairs that may drag on over months and years. Right at the start of the COVID-19 pandemic, I placed great emphasis on accurate documentation of the vaccination and infection status of my clients in order to ensure that data is systematically processed and that possible sequelae are spotted. The information we have gathered will now be evaluated and incorporated into our amended prophylactic program.

With this specific focus on prevention, we aim to identify and monitor potential long-term effects of SARS-CoV-2 infection. Long covid and post-covid are both sequelae of the disease, but they describe a very broad and elusive picture of diverse symptoms. As the pandemic has progressed, it has become increasingly clear that infection with SARS-CoV-2 can have long-term health consequences, even if the course of the disease itself is mild or is asymptomatic and therefore goes unnoticed. For this reason, I pay special attention to the sequelae of COVID-19 with the aim of defining these terms more precisely for our clients in the future.

At the same time, we also have to consider the possibility that certain symptom manifestations might instead be associated with vaccine damage and the long-term consequences of repeated vaccinations. More and more studies are producing information about the effects of the spike protein and about endothelial damage. However, we are surprised that there are no large-scale studies on possible carcinogenic effects or immunomodulatory changes so far. We will continue to keep this on our radar.

This specific focus on prevention in relation to the COVID-19 pandemic also shifts attention to the internal organs, where we are primarily looking at the kidney, liver, coronary arteries and the bronchial and neurological systems. Likewise, our prophylactic recommendations will also cover the relevant techniques and diagnostic methods. For example, we consider echocardiography (ultrasound examination) in cardiac and coronary artery diagnostics as no longer sufficient for our requirements and would therefore favor diagnostics based on a cardiac MRI scan.

In conclusion, I would like to inform my clients that we now intend to shorten the intervals for preventive care planning. This has the advantage that continuous monitoring of our clients and the availability of individualized data allows us to intervene at an early stage and thereby prevent damage in the long term.

Dr Robert Hess: Heavily mutated Covid variant has been identified.

Dr Robert HEss

Dr Robert Hess – 11/28/2021

Dr Robert Hess: Heavily mutated Covid variant has been identified, rapidly labelled a “variant of concern” and named Omicron.

Infection Omicron was first detected in South Africa last week, leading countries around the globe, including the United States, to impose travel restrictions on the southern African nation and at least seven others in the region. The new Omicron coronavirus variant kept spreading around the world on Sunday, with 13 cases found in the Netherlands and two each in Denmark and Australia, even as more countries tried to seal themselves off by imposing travel restrictions. The variant has now been detected in Britain, Germany, Italy, the Netherlands, Denmark, Belgium, Botswana, Israel, Australia and Hong Kong.

Omicron was first detected in South Africa last week, leading countries around the globe, including the United States, to impose travel restrictions on the southern African nation and at least seven others in the region. The new Omicron coronavirus variant kept spreading around the world on Sunday, with 13 cases found in the Netherlands and two each in Denmark and Australia, even as more countries tried to seal themselves off by imposing travel restrictions. The variant has now been detected in Britain, Germany, Italy, the Netherlands, Denmark, Belgium, Botswana, Israel, Australia and Hong Kong.

The discovery of Omicron, dubbed a “variant of concern” last week by the World Health Organization, has sparked worries around the world that it could resist vaccinations and prolong the nearly two-year COVID-19 pandemic. Omicron is potentially more contagious than previous variants, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains.

There have been many examples of variants that have seemed scary on paper, but came to nothing. The Beta variant was at the top of people’s concerns at the beginning of the year because it was the best at escaping the immune system. But in the end it was the faster-spreading Delta that took over the world. Beta was all immune escape and nothing else, Delta had infectivity and modest immune escape – Omicron potentially has both to high degrees.

What is this variant?
There are thousands of different types, or variants, of Covid circulating across the world. That’s to be expected because viruses mutate all the time. But this new variant, called B.1.1.529 or Omicron, has experts particularly worried because it is very different to the original Covid, which current vaccines were designed to fight. It has a long list of genetic changes – 50 in all. Of these, 32 are in the spike protein of the virus – the part which is the target of vaccines.

It is a rapidly evolving situation and we will keep you up to date with important findings. Omicron’s genetic profile has raised concerns, but there’s a shortage of real-world data that means nobody has the complete picture of what it can do.

Several vaccine manufacturers have announced measures against the new variant Omicron:
BioNTech and Pfizer are testing in the lab until about Dec. 10 how well their own already-approved vaccine protects against Omicron. If necessary, they will develop a vaccine adapted to the variant. Moderna is testing how well its licensed and the new variant-adapted vaccine candidates under development protect against Omicron. It is also directly initiating development of a vaccine adapted to Omicron. AstraZeneca is also evaluating how well its licensed vaccine protects against Omicron, according to the media report, and believes it can quickly develop an adapted vaccine if necessary. Janssen is also evaluating whether its own vaccine is protective, according to the media report. Novavax has started developing a variant of its own vaccine adapted to Omicron, according to the media report.

For now, this is just an update on the current situation and an initial assessment. In the course of the week, we will gain further insights and go into more detail on this topic. We will put current booster recommendations for our customers to the test again. Depending on how the situation develops, we may deviate from the original plan in some cases.